Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome.

Human papillomavirus (9-valent) vaccine is under clinical development by Xiamen Innovax Biotech and currently in Phase II for Human Papillomavirus Infections.

China is the world's top fish consumer and is spending billions on technology designed to restock the oceans. But will this ...

China’s Mainland Affairs Council (MAC) said they will investigate claims made in a YouTube video about China’s efforts to ...

Taiwan's Mainland Affairs Council is investigating claims from a video alleging China's political influence on young ...

Chinese conglomerate Xiamen C&D and Russia's Nornickel are in talks to create a joint venture in China to process Nornickel's ...

Marriott International, Inc. today announced the signing of an agreement with Xiamen Green Development Investment Group to ...

Univest Securities, LLC is acting as the sole placement agent.

In July, China unveiled a landmark resolution to set the stage for a new phase of reform aimed at advancing Chinese modernization. With a focus on the next five years, the blueprint outlines over 300 ...

International announced the signing of an agreement with Xiamen Green Development Investment Group to introduce The ...

The world’s largest maker of batteries for electric vehicles says it will get into battery swapping in China in a big way ...

Marriott International, Inc. today announced the signing of an agreement with Xiamen Green Development Investment Group to ...